Sara B. E. Andersson, Caroline Alvebratt, Christel A. S. Bergström: Controlled Suspensions Enable Rapid Determinations of Intrinsic Dissolution Rate and Apparent Solubility of Poorly Water-Soluble Compounds in Pharm. Res. 39 (2017) 1805–1816, doi:10.1007/s11095-017-2188-1.
Rocío Reinoso‐Arija, Cecilia López‐Ramírez, José Antonio Jimenez‐Ruiz, José Luis López‐Campos: Effectiveness of aprepitant in post‐acute COVID19 syndrome. In: Clinical Case Reports. Band9, Nr.9, September 2021, doi:10.1002/ccr3.4646, PMID 34567551, PMC 8449093 (freier Volltext).
Rocío Reinoso‐Arija, Cecilia López‐Ramírez, José Antonio Jimenez‐Ruiz, José Luis López‐Campos: Effectiveness of aprepitant in post‐acute COVID19 syndrome. In: Clinical Case Reports. Band9, Nr.9, September 2021, doi:10.1002/ccr3.4646, PMID 34567551, PMC 8449093 (freier Volltext).
rote-liste.de
Präparate: Aprepitant. In: Rote Liste. Rote Liste Service GmbH, abgerufen am 4. Januar 2022.